Advertisement

Liver Cancer pp 159-181 | Cite as

Focal Liver Lesion: Nonlinear Contrast-Enhanced Ultrasound Imaging

  • Vincenzo Migaleddu
  • Giuseppe Virgilio
Part of the Methods of Cancer Diagnosis, Therapy and Prognosis book series (HAYAT, volume 5)

Ultrasound (US) is the most widespread imaging modality for screening focal liver lesions. Noninvasive diagnosis (detection and characterization) of focal liver lesions is still carried out in many centers by computerized tomography (CT) and magnetic resonance (MR) using contrast agents. Hepatic lesions have in effect characteristic perfusion and enhancement patterns during the various vascular phases, which assist characterization and in many cases make definite diagnosis possible. Conventional and Doppler US are often limited in diagnosing this kind of lesion as color Doppler vascular information of the lesion is limited (see chapter 11).

Recently, the detection and characterization of focal hepatic lesions by US has increased considerably due to the development of new nonlinear (harmonic and nonlinear fundamental) technologies that optimize detection of contrast agents. Furthermore, small lesions may not be well defined by CT or MR imaging because real-time visualization of lesion vascularization is not possible. Because contrast-enhanced US (CEUS) is a dynamic analysis that allows this, small lesions may be detected that are sometimes missed with CT or MR imaging. Positron emission tomography (PET) is proving to be a molecular imaging modality with very high sensitivity, but not competitive as the advantages do not outweigh the high cost of the exam.

Keywords

Contrast Agent Arterial Phase Mechanical Index Focal Liver Lesion Harmonic Imaging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abbey-Toby, A., Cazals-Hatem, D., Colombat, M., Belghiti, J., Vilgrain, V., and Degott, C. 2003. Inflammatory pseudo-tumor of the liver: is pre-operative diagnosis possible? Gastroenterol. Clin. Biol. 27: 883–890.PubMedGoogle Scholar
  2. Akahn, O., and Pringot, J. 2002. Imaging of abdominal tubercolosis. Eur. Radiol. 12: 321–323.Google Scholar
  3. Albrecht, T., Hoffmann, C.W., Schmitz, S.A., Schettler, S., Ovemberg, A., Germen, C.T., and Wolf, K.J. 2001. Phase-inversione sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. Am. J. Roentgenol. 176 (5): 1191–1198.Google Scholar
  4. Albrecht, T., Blomley, M.J., Burns, P.N., Wilson, S., Harvey, C.J., Leen, E., Claudon, M., Calliada, F., Correas, J.M., LaFortune, M., Campani, R., Hoffmann, C.W., Cosgrove, D.O., and LeFevre, F. 2003a. Improved detecion of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 505A: multicenter study. Radiology 227: 361–370.CrossRefGoogle Scholar
  5. Albrecht, T., Oldenburg, A., Hohmann, J., Skrok, J., Hoffmann, C.W., Schettler, S., and Wolf, K.J. 2003b. Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and SonoVue. Eur. Radiol. 13 (Suppl 3): 79–86.CrossRefGoogle Scholar
  6. Albrecht, T., Hohmann, J., Oldenburg, A., Skrok, J., and Wolf, K.J. 2004. Detection and characterisation of liver metastases. Eur. Radiol. 14 (Suppl 8): 25–33.CrossRefGoogle Scholar
  7. Apfel, R.E., and Holland, C.K. 1991. Gauging the likelihood of cavitation from short-pulse, low duty cycle diagnostic ultrasound. Ultrasound Med. Biol. 17: 175–185.CrossRefGoogle Scholar
  8. Bartolozzi, C., Cioni, D., Donati, F., and Lencioni, R. 2001. Focal liver lesions: MR imaging-patho-logic correlation. Eur. Radiol. 11: 1374–1388.PubMedCrossRefGoogle Scholar
  9. Bleuzen, A., and Tranquart, F. 2004. Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue. Eur. Radiol. 14 (Suppl 8): 53–62.CrossRefGoogle Scholar
  10. Brauner, M., Buffard, M.D., Jaentils, V., Legrand, I., and Gotheil, C. 1989. Sonography and computed tomography of mocroscopic tuberculosis of the liver. J. Clin. Ultrasound 17: 563–568.PubMedCrossRefGoogle Scholar
  11. Brú, C., Marotto, A., Bruix, J., Faus, R., Biachi, L., Calvet, X., Ayuso, C., Vilana, R., Gilalbert, R., and Rodes, J. 1989. Diagnostic accurancy of fine-needle biopsy in patients with hepatocellular carcinoma. Dig. Dis. Sci. 34: 1765–1769.PubMedCrossRefGoogle Scholar
  12. Bruix, J., and Sherman, M., 2005. Management of Hepatocellular carninoma. J. Hepatol. 42: 1208–1236.CrossRefGoogle Scholar
  13. Bruix, J., Sherman, M., Llovet, J.M., Beaugrand, M., Lencioni, R., Burroughs, A.K., Christensen, E., Pagliaro, L., Colombo, M., and Rodes, J. 2001. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona. EASL Conference. J. Hepatol. 35: 421–430.PubMedCrossRefGoogle Scholar
  14. Burns, P.N., Wilson, S.R., and Simpson, D.H. 2000. Pulse inversion imaging of liver blood flow: an improved method for characterization of focal masses with microbubble contrast. Invest. Radiol. 35: 58–71.PubMedCrossRefGoogle Scholar
  15. Catalano, O., Nunziata, A., Lobianco, R., and Siani, A. 2005. Real-time harmonic contrast material-specific US of focal liver lesions. RadioGraphics 25: 333–349.PubMedCrossRefGoogle Scholar
  16. Chin C.T., and Burns P.N. 1997. Predicting the acoustic response of a microbubble population for contrast imaging. In: IEEE Ultrason. Symp. 22: 1557–1560.Google Scholar
  17. Clarke, M.P., Kane, R.A., Steele, G. Jr., Hamilton, E.S., Ravikumar, T.S., Onik, G., and Clouse, M.E. 1989. Prospective comparision of pre-operative imaging and intraoperative ultrasonog-raphy in the detecion of liver tumours. Surgery 106: 849–855.PubMedGoogle Scholar
  18. Conlon, R., Jacobs, M., Dasgupta, D., and Loge, J.P. 2003. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonace imaging. Eur. Ultrasound 16: 211–216.CrossRefGoogle Scholar
  19. Cosgrove, D.O. 2001. Malignant liver disease. In: Meire, H.B., Cosgrove, D.O., Dewbury, K.C., and Farrant, P. (eds). Clinical Ultrasound: A Comprehensive Text. Abdominal and General Ultrasound, vol. 1, 2nd ed. Churchill Livingstone, London, 211–231.Google Scholar
  20. Cosgrove, D.O. 2005. Harmonic imaging: tissue and microbubbles in http://www.smirg.org/lec-tures.php.
  21. De Baere, T., Elias, D., Dromain, C., Din, M.G., Kuoch, V., Ducreux, M., Boige, V., Lassau, N., Marteau, V., Lasser, P., and Roche, A. 2000. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. Am. J. Roentgenol. 175: 1619–1625.Google Scholar
  22. Dodd, G.D. 3rd., Soulen, M.C., Kane, R.A., Livraghi, T., Lees, W.R., Yamashita, Y., Gillams, A.R., Karahan, O.I., and Rhim, H. 2000. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 20: 9–21.PubMedGoogle Scholar
  23. EFSUMB Study Group Albrecht, T., Blomley, M., Bolondi, L., Claudon, M., Correas, J.M., Cosgrove, D., Greiner, L., Jager, K., Jong, N.D., Leen, E., Lencioni, R., Lindsell, D., Martegani, A., Solbiati, L., Thorelius, L., Tranquart, F., Weskott, H.P., and Whittingham, T. 2004. Guidelines for the Use of Contrast Agents in Ultrasound. Ultraschall. Med. 25: 249–256.PubMedCrossRefGoogle Scholar
  24. Fracanzani, A.L., Burdick, L., Borzio, M., Roncalli, M., Bonelli, N., Borzio, F., Maraschi, A., Fiorelli, G., and Fargion, S. 2001. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology 34: 1109–1112.PubMedCrossRefGoogle Scholar
  25. Goldberg, S.N., Gazelle, C.S., Compton, C.C., Mueller, P.R., and Tanabe, K.K. 2000. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88: 2452–2463.PubMedCrossRefGoogle Scholar
  26. Golli, M., Van Nhieu, J.T., Mathieu, D., Zafrani, E.S., Cherqui, D., Dhumeaux, D., Vasile, N., and Rahmouni, A. 1994. Hepatocellular adenoma: Color Doppler US and pathologic correlations. Radiology 190: 741–744.PubMedGoogle Scholar
  27. Grazioli, L., Federle, M.P., Ichikawa, T., Balzano, E., Nalesnik, M., and Madariaga, J. 2000. Liver adenomatosis: clinical, histopathologic and imaging findings in 15 patients. Radiology 216: 395–402.PubMedGoogle Scholar
  28. Greis, C. 2004. Technology overview: SonoVue (Bracco, Milan). Eur. Radiol. 14 (Suppl 8): 11–15.CrossRefGoogle Scholar
  29. Hamilton, M.F., and Blackstock, D.T. 1998. Nonlinear Acoustics. Academic, San Diego, CA.Google Scholar
  30. Harvey, C.J., and Albrecht, T. 2001. Ultrasound of focal liver lesions. Eur. Radiol. 11: 1578–1593.PubMedCrossRefGoogle Scholar
  31. Harvey, C.J., Blomley, M.J., Eckersley, R.J., Cosgrove, D.O., Patel, N., Heckemann, R.A., and Butler-Barnes, J. 2000. Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SH U 508A-early experience. Radiology 216: 903–908.PubMedGoogle Scholar
  32. Horiuchi, R., Uchida, T., Kojima, T., and Shikata, T. 1990. Inflammatory pseudotumor of the liver. Clinicalpathological study and review of literature. Cancer 65: 1583–1590.PubMedCrossRefGoogle Scholar
  33. Howell, J.D., Wotherspoon, H., Leen, E., Cooke, T.C., and MacArlde, C.S. 1999. Evaluation of a follow up programme after curative resection for colorectal cancer. Br. J. Cancer 79: 308–310.PubMedCrossRefGoogle Scholar
  34. Ishak, K.G., Anthony, P.P., and Sobin, L.H. 1994. World Health Organization: International Histo-logic Classification of Tumors, 2nd ed. Berlin, Springer.Google Scholar
  35. Iwase, K., Higaki, J., Yoon, H.E., Mikata, S., Miyazaki, M., Torikai, K., Shirai,Y., Awai, K., Imakita, M., and Kamiike, W. 2002. Solitary necrotic nodule of the liver. J. Hepatobiliary Pancreat. Surg. 9: 120–124.PubMedCrossRefGoogle Scholar
  36. Jang, H.J., Choi, B.I., Kim, T.K., Jun, A.J., Kim., K.W., Han, J.K., and Han, M.C. 1998. Atypical small hemangiomas of the liver: “bright dot” sign at two-phase spiral CT. Radiology 208: 543–548.PubMedGoogle Scholar
  37. Karhunen, P.J. 1986. Benign hepatic tumours and tumour-like conditions in men. Clin. Pathol. 39: 183–188.CrossRefGoogle Scholar
  38. Kim, C.K., Lim, J.H., and Lee, W.J. 2001. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonogra-phy in transplant patients. J. Ultrasound Med. 20: 99–104.PubMedGoogle Scholar
  39. Kroncke, T.J., Taupitz, M., Kivelitz, D., Scheer, I., Daberkow, U., Rudolph, B., and Hamm, B. 2000. Multifocal nodular fatty infiltration of the liver mimicking metastatic disease on CT: imaging findings and diagnosis using MR imaging. Eur. Radiol. 10: 1095–1100.PubMedCrossRefGoogle Scholar
  40. Leen, E., Angerson, W.J., Yarmenitis, S., Bongartz, G., Blomley, M., Del Maschio, A., Summaria, V., Maresca, G., Pezzoli, C., and Llul, J.B. 2002. Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur. J. Radiol. 42: 200–206.CrossRefGoogle Scholar
  41. Lencioni, R., Pinto, F., Armillota, N., and Bartolozzi, C. 1996. Assessment of tumor vasco-larity in hepatocarcinoma: comparison of power Doppler and Color Doppler US. Radiology 201: 353–358.PubMedGoogle Scholar
  42. Lencioni, R.A., Allgaier, H.P., Cioni, D., Olschewski, M., Deibert, P., Crocetti, L., Frings, H., Laubenberger, J., Zuber, I., Blum, H.E., and Bartolozzi, C. 2003. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutanous ethanol injection. Radiology 228: 235–240.PubMedCrossRefGoogle Scholar
  43. Levine, C. 1990. Primary macronodular hepatic tuberculosis: US and CT appearances. Gastro-intest. Radiol. 15: 307–309.CrossRefGoogle Scholar
  44. Livraghi, T. 2006. Role of image-guided therapies in hepatocellular carcinoma in http://www. smirg.org/lectures.php.
  45. Livraghi, T., Benedini, V., Lazzaron, S., Meloni, F., Torzilli, G., and Vettori, C. 1998. Long term results of single session PEI in patients with large hepatocellular carcinoma. Cancer 83: 48–57.PubMedCrossRefGoogle Scholar
  46. Livraghi, T., Meloni, F., Morabito, A., and Vettori, C. 2004. Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liver Transpl. 10: 98–106.CrossRefGoogle Scholar
  47. Matsui, O., Kadoja, M., Kamejama, T., Takashima, T., Nakanuma, J., Unoura, M., Kobayashi, K., Izumi, R., and Ida, M. 1991. Benign and malignant nodules in cirrhotic patients: distinction on blood supply. Radiology 178: 493–497.PubMedGoogle Scholar
  48. Migaleddu, V., Virgilio, G., Campisi, G., Sirigu, D., and Canalis, G.C. 2002. Conventional ultra-sonography versus tissue harmonic imaging for the assessment of the common bile duct in chole-cystectomized patients. Radiol. Med. 103: 1–6.Google Scholar
  49. Migaleddu, V., Virgilio, G., Turilli, D., Conti, M., Campisi, G., Canu, M., Sirigu, D., and Vincentelli, I. 2004. Charaterization of focal liver lesions in real-time using harmonic imaging with high mechanical index and contrast agent levovist. Am. J. Roentgenol. 182: 1505–1512.Google Scholar
  50. Migaleddu, V., Manca, A., Turilli, D., Luciano, P., Canu, N., Campisi, G., and Virgilio, G. 2005. Fundamental nonlinear imaging versus harmonic imaging with contrast medium sonovue in the evaluation of the hepatic focal lesions: preliminary results. Eur. Radiol. 14 (Suppl. 1): B-126.Google Scholar
  51. Mirilas, P., and Skandalakis, J.E. 2002. Benign anatomical mistakes: incidentaloma. Am. Surg. 68: 1026–1028.PubMedGoogle Scholar
  52. Moody, A.R., and Wilson, S.R. 1993. Atypical hepatic hemangioma: a suggestive sonographic morphology. Radiology 188: 413–417.PubMedGoogle Scholar
  53. Morel, D.R., Schwieger, I., Hohn, L., Terrettaz. J., Llull, J.B., Cornioley, Y.A., and Schneider, M. 2000. Human pharmacokinectics and safety evaluation of SonoVueTM, a new contrast agent for ultrasound imaging. Invest. Radiol. 35 (Suppl 1): 80–85.PubMedCrossRefGoogle Scholar
  54. Nam, K.J., Kang, H.K., and Lim, J.H. 1996. Inflammatory pseudotumor of the liver: CT and sonographic features. Am. J. Roentgenol. 167: 485–487.Google Scholar
  55. Nanda, N.C., and Carstensen, E.L. 1997. Echo-enhancing agents: safety. In: Nanda N.C., Schlief, R., and Goldberg, B.B. (eds). Advances in Echo Imaging Using Contrast Enhancement, 2nd, ed.Kluwer, Dordrecht, 139–170.Google Scholar
  56. Nicolau, C., Vilana, R., and Brù, C. 2004. The use of contrast-enhanced ultrasound in the management of the cirrothic patient and for detection of HCC. Eur. Radiol. 14 (Suppl 8): 63–71.CrossRefGoogle Scholar
  57. Nicolau, C., Vilana, R., Catalá, V., Bianchi, L., Gilabert, R., Carcía, A., and Brú, C. 2006. Importance of evaluating all vascular phases on contrast enhanced sonography in the diferentia-tion of benign from malignant focal lesions. Am. J. Roentgenol. 186: 158–167.CrossRefGoogle Scholar
  58. Nordic Gastrointestinal Tumour Adjuvant Therapy Group, 1992. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer; a randomisede trial. J. Clin. Oncol. 10: 904–911.Google Scholar
  59. Numata, K., Tanaka, K., Kiba, T., Norimoto, M., Arata, S., Kondo, M., and Sekihara, H. 1997. Use of hepatic tumor index on color Doppler sonography for differentiating large hepatic tumors. Am. J. Roentgenol. 168: 991–995.Google Scholar
  60. Ortega, D., Burns, P.N., Simpson, D.H., and Wilson, S.R. 2001. Tissue harmionic imaging: is it a benefit for bile duct sonography? Am. J. Roentgenol. 176: 653–659.Google Scholar
  61. Phillips, P., and Gardner, E. 2004. Contrast-agent detection and quantification. Eur. Radiol. 14 (Suppl 8): 4–10.CrossRefGoogle Scholar
  62. Powers, J.E., Burns, P.N., and Souquet, J. 1997. Imaging instrumentation for ultrasound contrast agents. In: Nanda, N.C., Schlief, R., and Goldberg, B.B. (eds). Advances in Echo Imaging Using Contrast Enhancement, 2nd, ed. Kluwer, Dordrecht, 139–170.Google Scholar
  63. Quaia, E., Calliada, F., Bertolotto, M., Rossi, S., Garioni, L., Rosa, L., and Pozzi-Mucelli, R. 2004. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexaflu-oride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232: 420–430.PubMedCrossRefGoogle Scholar
  64. Ros, P., and Davis, G. 1998. The incidental focal liver lesion: photon, proton, or needle? Hepatology 98: 1183–1190.CrossRefGoogle Scholar
  65. Ros, P.R., Menu, Y., Vilgrain, V., Mortele, K.J., and Terris, B. 2001. Liver neoplasms and tumor-like conditions. Eur. Radiol. 11 (Suppl 2): 145–165.Google Scholar
  66. Schneider, M., Arditi, M., Barrau, M.B., Brochot, J., Broillet, A., Ventron, R., and Yan, F. 1995. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbub-bles. Invest. Radiol. 30: 451–457.PubMedCrossRefGoogle Scholar
  67. Schwartz, L.H., Gandras, E.J., Colangelo, S.M., Ercolani, M.C., and Panicek, D.M. 1999. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210: 71–74.PubMedGoogle Scholar
  68. Siösteen, A.K., and Elvin, A. 2004. Intra-operative uses of contrast-enhanced ultrasound. Eur. Radiol. 14 (Suppl 8): 87–95.CrossRefGoogle Scholar
  69. Solbiati, L., Livraghi, T., Golberg, S.N., Ierace, T., Meloni, F., Dellanoce, M., Cova, L., Halpern, E.F., and Gazelle, G.S. 2001. Percutaneous radio-frequency ablation of liver metastase from colon rectal cancer: long term risults 117 patients. Radiology 221: 159–166.PubMedCrossRefGoogle Scholar
  70. Solbiati, L., Tonolini, M., and Cova, L. 2004. Monitoring RF ablation. Eur. Radiol. 14 (Suppl 8): 34–42.CrossRefGoogle Scholar
  71. Tanaka, S., Kitamura, T., Fuijta, M., Nakanishi, K., and Okuda, S. 1990. Color Doppler flow imaging of liver tumors. Am. J. Roentgenol. 154: 509–514.Google Scholar
  72. Tanaka, S., Ioka, T., Oshikawa, O., Hamada, Y., and Yoshioka, F. 2001. Dynamic sonography of hepatic tumors. Am. J. Roentgenol. 177: 799–805.Google Scholar
  73. Torzilli, G., Del Fabro, D., Palmisano, A., Donadon, M., Bianchi, P., Roncalli, M., Balzarini, L., and Montorsi, M. 2005. Contrast-enhanced intraoperative ultrasonography during hepatectomies for Colon rectal metastaes. J. Gastrointest. Surg. 9: 1148–1154.PubMedCrossRefGoogle Scholar
  74. Ueda, K., Terada, T., Nakanuma, Y., and Matsui, O. 1992. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a mor-phometric study. Hum. Pathol. 23: 619–626.PubMedCrossRefGoogle Scholar
  75. Unal, O., Sakarya, M.E., Arslan, H., Tuncer, I., and Etlik, O. 2002. Hepatic cavernous hemangi-omas: patterns of contrast enhancement on MR fluoroscopy imaging. Clin. Imaging 26: 39–42.PubMedCrossRefGoogle Scholar
  76. Volk, M., Strotzer, M., Lenhart, M., Techert, J., Seitz, J., and Feuerbach, S. 2001. Frequency of benign hepatic lesions incidentally detected with contrast-enhanced section portal venous pahase spiral CT. Acta Radiol. 42: 172–175.PubMedCrossRefGoogle Scholar
  77. Ward, B., Baker, A.C., and Humprey, V.F. 1997. Non linear propagation applied to the improvement of resolution in diagnostic medical ultrasound. J. Acoust. Soc. Am. 101: 143–154.PubMedCrossRefGoogle Scholar
  78. Ward, J., and Robinson, J. 2002. How to detect hepatocellular carcinoma in chirrhosis. Eur. Radiol. 12: 2258–2272.PubMedGoogle Scholar
  79. Wen, Y.L., Kudo, M., Zheng, R.Q., Ding, H., Zhou, P., Minami, Y., Chung, H., Kitano, M., Kawasaki, T., and Maekawa, K. 2004. Characterizazione of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. Am. J. Roentgenol. 182: 1019–1026.Google Scholar
  80. Zhang, B.H., Yang, B.H., and Tang, Z.Y. 2004. Randomized controll trial of screening for hepa-tocellular carcinoma. J. Cancer Res. Clin. Oncol. 130: 417–422.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media B.V. 2009

Authors and Affiliations

  • Vincenzo Migaleddu
    • 1
  • Giuseppe Virgilio
    • 1
  1. 1.Sardinian Mediterranean Imaging GroupSassariItaly

Personalised recommendations